Murelli Ryan P, D'Erasmo Michael P, Hirsch Danielle R, Meck Christine, Masaoka Takashi, Wilson Jennifer A, Zhang Baofeng, Pal Rajat K, Gallicchio Emilio, Beutler John A, Le Grice Stuart F J
Department of Chemistry, Brooklyn College, The City University of New York, Brooklyn, New York, USA; PhD Program in Chemistry, The Graduate Center of The City University of New York, New York, NY, USA.
Basic Research Laboratory, Center for Cancer Research, National Cancer Institute at Frederick, Frederick, MD, USA.
Medchemcomm. 2016 Sep 1;7(9):1783-1788. doi: 10.1039/C6MD00238B. Epub 2016 Jul 7.
HIV Reverse Transcriptase-associated ribonuclease H activity is a promising enzymatic target for drug development that has not been successfully targeted in the clinic. While the α-hydroxytropolone-containing natural products β-thujaplicinol and manicol have emerged as some of the most potent leads described to date, structure-function studies have been limited to the natural products and semi-synthetic derivatives of manicol. Thus, a library of α-hydroxytropolones synthesized through a convenient oxidopyrylium cycloaddition/ring-opening sequence have been tested in and cell-based assays, and have been analyzed using computational support. These studies reveal new synthetic α-hydroxytropolones that, unlike the natural product leads they are derived from, demonstrate protective antiviral activity in cellular assays.
HIV逆转录酶相关的核糖核酸酶H活性是药物开发中一个有前景的酶靶点,但在临床上尚未成功靶向。虽然含α-羟基托酚酮的天然产物β-崖柏素和马尼醇已成为迄今为止描述的一些最有效的先导化合物,但结构-功能研究仅限于马尼醇的天然产物和半合成衍生物。因此,通过便捷的氧化吡啶环加成/开环序列合成的α-羟基托酚酮库已在体外和基于细胞的试验中进行了测试,并使用计算辅助进行了分析。这些研究揭示了新的合成α-羟基托酚酮,与它们所衍生的天然产物先导化合物不同,它们在细胞试验中表现出保护性抗病毒活性。